336 related articles for article (PubMed ID: 9869571)
1. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.
Edelstein PH; Edelstein MA; Lehr KH; Ren J
J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Shinzato T; Doyle E; Edelstein MA
Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Higa F; Edelstein MA
Antimicrob Agents Chemother; 2001 Oct; 45(10):2685-90. PubMed ID: 11557455
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB
Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101
[TBL] [Abstract][Full Text] [Related]
6. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
Edelstein PH; Shinzato T; Edelstein MA
J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Edelstein MA; Holzknecht B
Antimicrob Agents Chemother; 1992 Nov; 36(11):2387-91. PubMed ID: 1489182
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A
J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
[TBL] [Abstract][Full Text] [Related]
9. Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Edelstein MA; Ren J; Polzer R; Gladue RP
Antimicrob Agents Chemother; 1996 Feb; 40(2):314-19. PubMed ID: 8834872
[TBL] [Abstract][Full Text] [Related]
10. Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Weiss WJ; Edelstein MA
Antimicrob Agents Chemother; 2003 Feb; 47(2):533-40. PubMed ID: 12543655
[TBL] [Abstract][Full Text] [Related]
11. Review of azithromycin activity against Legionella spp.
Edelstein PH
Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila.
Baltch AL; Smith RP; Ritz WJ; Franke MA; Michelsen PB
J Antimicrob Chemother; 2000 Jul; 46(1):51-5. PubMed ID: 10882688
[TBL] [Abstract][Full Text] [Related]
13. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
Kohno S; Koga H; Yamaguchi K; Masaki M; Inoue Y; Dotsu Y; Masuyama Y; Hayashi T; Hirota M; Saito A
J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201
[TBL] [Abstract][Full Text] [Related]
14. In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila.
Edelstein PH; Hu B; Edelstein MA
Antimicrob Agents Chemother; 2005 Jun; 49(6):2533-5. PubMed ID: 15917565
[TBL] [Abstract][Full Text] [Related]
15. In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila.
Sato T; Tateda K; Kimura S; Ishii Y; Yamaguchi K
Antimicrob Agents Chemother; 2011 Apr; 55(4):1594-7. PubMed ID: 21220530
[TBL] [Abstract][Full Text] [Related]
16. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease.
Fitzgeorge RB; Lever S; Baskerville A
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():171-6. PubMed ID: 8396090
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of severe respiratory infection. Legionella pneumonia].
Saito A
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):281-5. PubMed ID: 2615084
[TBL] [Abstract][Full Text] [Related]
19. The effect of antibiotics on the growth of Legionella pneumophila in guinea-pig alveolar phagocytes infected in vivo by an aerosol.
Fitzgeorge RB
J Infect; 1985 May; 10(3):189-93. PubMed ID: 3161953
[TBL] [Abstract][Full Text] [Related]
20. The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs.
Saito A; Koga H; Shigeno H; Watanabe K; Mori K; Kohno S; Shigeno Y; Suzuyama Y; Yamaguchi K; Hirota M
J Antimicrob Chemother; 1986 Aug; 18(2):251-60. PubMed ID: 3759736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
